Dillard's (DDS) Surpasses Q3 Earnings and Revenue Estimates
Dillard's (DDS) came out with quarterly earnings of $8.31 per share, beating the Zacks Consensus Estimate of $6.43 per share. This compares to earnings of $7.73 per share a year ago.
Dillard's Pre-Q3 Earnings Indicate Mixed Trends: Is It Worth Buying?
DDS's Q3 outlook indicates pressure on sales and profits, though store upgrades and e-commerce gains may soften the impacts.
Analysts Estimate Dillard's (DDS) to Report a Decline in Earnings: What to Look Out for
Dillard's (DDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dillard's (DDS) Upgraded to Buy: Here's Why
Dillard's (DDS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Dillard's, Inc. (DDS) Hits Fresh High: Is There Still Room to Run?
Dillard's (DDS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Dillard's (DDS) Upgraded to Strong Buy: Here's What You Should Know
Dillard's (DDS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Dillard's (DDS) Is Up 9.47% in One Week: What You Should Know
Does Dillard's (DDS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Dillard's: Rating Upgrade As There Are Positive Green Shoots
I am shifting my rating on Dillard's from sell to hold after 2Q25, as positive same-store sales growth marks a key milestone. Despite encouraging sales momentum and improved category mix, profitability remains under pressure, with gross margin contraction and persistent inventory risks. The recovery story is still uncertain, with uneven demand across categories and earnings growth yet to inflect meaningfully.
Dillard's Q2 Earnings Beat Estimates, Comparable Store Sales Rise 1%
DDS' Q2 earnings topped estimates, with EPS up 1.5% and comps rising 1%, lifting shares 3.4% as sales momentum improved.
Add These 4 Top-Performing Liquid Stocks to Boost Portfolio Returns
NYT, DDS, NEM and FTDR make the cut as top liquid stocks, with each boasting strong liquidity, growth attributes and operational efficiency.
Dillard's Remains A Problematic Long-Term Play
Dillard's posted better-than-expected Q2 revenue and EPS, but long-term trends show declining revenue, profits, and cash flows. Management prioritizes dividends and buybacks over reinvestment, risking the company's long-term health for short-term shareholder returns. Despite a strong cash position and seemingly fair valuation, Dillard's trades at a premium to peers and faces ongoing operational headwinds.
Buy Dillard's (DDS) Stock After Crushing Q2 EPS Expectations?
Dillard's was able to crush Q2 EPS expectations on Thursday thanks to its operational efficiency, modest sales growth, and shareholder-friendly capital allocation.
